. 2022 Nov 12;62(2):1027–1039. doi: 10.1007/s00394-022-03051-2

Table 3.

Changes in cortisol, alkaline phosphatase (ALP), monocyte-chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), interleukin-8 (IL-8) in the three trials

	CP	CON	REST
Cortisol (nmol/L)
Pre	413.2 ± 127.0	392.4 ± 105.1	403.0 ± 157.7
Post	446.3 ± 135.8^ab	428.3 ± 106.0^ab	295.5 ± 97.8a
2 h post	287.1 ± 103.0^a	261.9 ± 63.7^a	261.6 ± 59.5^a
ALP (IU/L)
Pre	66.7 ± 17.3	65.5 ± 16.4	64.1 ± 18.2
Post	66.0 ± 17.6	65.4 ± 17.3	66.8 ± 18.4
2 h post	67.5 ± 18.3	67.0 ± 16.7	67.4 ± 18.4
MCP-1 (pg/ml)
Pre	17.0 ± 11.4	14.6 ± 9.0	18.1 ± 12.6
Post	24.6 ± 13.7^ab	25.4 ± 15.1^ab	11.4 ± 5.8^a
2 h post	19.1 ± 12.3^b	19.1 ± 10.3^ab	10.7 ± 5.5^a
IL-6 (pg/ml)
Pre	3.6 ± 6.4	4.0 ± 6.7	4.6 ± 8.2
Post	6.2 ± 6.5^ab	7.6 ± 8.6^ab	3.9 ± 6.5
2 h post	4.6 ± 5.5^ab	5.1 ± 4.7^ab	3.7 ± 6.7
IL-8 (pg/ml)^#
Pre	4.4 ± 2.9	4.3 ± 2.1	4.2 ± 2.1
Post	5.1 ± 2.5	5.0 ± 2.3^a	4.0 ± 2.2
2 h post	4.9 ± 2.6	5.5 ± 3.1^a	4.1 ± 2.2

CP collagen peptides trial, CON control trial, REST no exercise rest trial.

^#n = 17 Due to analytical difficulties

^aTime effects vs. pre: P < 0.05

^bInteraction effect vs. rest: P < 0.05